BioMarin Presents New Data Advancing Understanding of Achondroplasia and Hypochondroplasia Treatment at the American Society for Bone and Mineral Research Annual Meeting

Summary

BioMarin presented new data on VOXZOGO (vosoritide) demonstrating impact on foramen magnum and craniocervical junction growth in children with achondroplasia at the American Society for Bone and Mineral Research Annual Meeting.